Robeco Institutional Asset Management B.V. Vertex Pharmaceuticals Inc Transaction History

Robeco Institutional Asset Management B.V.

  • $50.6 Billion
  • Q1 2025

A detailed history of Robeco Institutional Asset Management B.V. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Robeco Institutional Asset Management B.V. holds 146,000 shares of VRTX stock, worth $74.4 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
146,000
Previous 286,756 49.09%
Holding current value
$74.4 Million
Previous $115 Million 38.7%
% of portfolio
0.14%
Previous 0.22%

Shares

43 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

Apr 23, 2025
SELL
$402.49 - $513.76 $56.7 Million - $72.3 Million
-140,756 Reduced 49.09%
146,000 $70.8 Million
Q4 2024

Jan 22, 2025
SELL
$396.64 - $516.74 $3.89 Million - $5.07 Million
-9,812 Reduced 3.31%
286,756 $115 Million
Q3 2024

Oct 29, 2024
SELL
$460.0 - $505.78 $33.9 Million - $37.2 Million
-73,643 Reduced 19.89%
296,568 $138 Million
Q2 2024

Jul 22, 2024
SELL
$392.81 - $485.53 $36.8 Million - $45.5 Million
-93,658 Reduced 20.19%
370,211 $174 Million
Q1 2024

Apr 24, 2024
BUY
$407.69 - $446.08 $2.46 Million - $2.7 Million
6,045 Added 1.32%
463,869 $194 Million
Q4 2023

Feb 14, 2024
BUY
$343.0 - $410.68 $72.9 Million - $87.3 Million
212,636 Added 86.72%
457,824 $186 Million
Q4 2023

Feb 08, 2024
SELL
$343.0 - $410.68 $64.4 Million - $77.1 Million
-187,749 Reduced 43.37%
245,188 $458 Million
Q3 2023

Oct 23, 2023
BUY
$338.18 - $362.46 $8.97 Million - $9.61 Million
26,523 Added 6.53%
432,937 $151 Million
Q2 2023

Jul 24, 2023
SELL
$314.42 - $351.91 $12.7 Million - $14.2 Million
-40,403 Reduced 9.04%
406,414 $143 Million
Q1 2023

May 03, 2023
SELL
$283.23 - $323.1 $7.12 Million - $8.12 Million
-25,140 Reduced 5.33%
446,817 $141 Million
Q4 2022

Feb 06, 2023
BUY
$285.76 - $321.48 $38 Million - $42.7 Million
132,927 Added 39.21%
471,957 $136 Million
Q3 2022

Dec 01, 2022
BUY
$273.83 - $305.53 $23.3 Million - $26 Million
85,003 Added 33.46%
339,030 $98.2 Million
Q3 2022

Oct 26, 2022
BUY
$273.83 - $305.53 $23.3 Million - $26 Million
85,003 Added 33.46%
339,030 $98.2 Million
Q2 2022

Dec 01, 2022
BUY
$234.96 - $292.55 $4.04 Million - $5.03 Million
17,195 Added 7.26%
254,027 $71.6 Million
Q2 2022

Jul 27, 2022
BUY
$234.96 - $292.55 $4.04 Million - $5.03 Million
17,195 Added 7.26%
254,027 $71.6 Million
Q1 2022

Dec 01, 2022
BUY
$221.42 - $260.97 $8.53 Million - $10.1 Million
38,514 Added 19.42%
236,832 $61.8 Million
Q1 2022

Apr 26, 2022
BUY
$221.42 - $260.97 $8.53 Million - $10.1 Million
38,514 Added 19.42%
236,832 $61.8 Million
Q4 2021

Dec 01, 2022
SELL
$177.01 - $223.45 $820,795 - $1.04 Million
-4,637 Reduced 2.28%
198,318 $43.6 Million
Q4 2021

Jan 31, 2022
SELL
$177.01 - $223.45 $820,795 - $1.04 Million
-4,637 Reduced 2.28%
198,318 $43.6 Million
Q3 2021

Dec 01, 2022
SELL
$181.39 - $202.99 $23,943 - $26,794
-132 Reduced 0.06%
202,955 $36.8 Million
Q3 2021

Oct 20, 2021
SELL
$181.39 - $202.99 $23,943 - $26,794
-132 Reduced 0.06%
202,955 $36.8 Million
Q2 2021

Dec 01, 2022
BUY
$187.49 - $221.1 $4.99 Million - $5.88 Million
26,595 Added 15.07%
203,087 $41 Million
Q2 2021

Jul 28, 2021
BUY
$187.49 - $221.1 $4.99 Million - $5.88 Million
26,595 Added 15.07%
203,087 $41 Million
Q1 2021

Dec 01, 2022
SELL
$207.02 - $241.31 $33.6 Million - $39.2 Million
-162,538 Reduced 47.94%
176,492 $37.9 Million
Q1 2021

Apr 23, 2021
SELL
$207.02 - $241.31 $23.2 Million - $27 Million
-112,005 Reduced 38.82%
176,492 $37.9 Million
Q4 2020

Dec 01, 2022
SELL
$207.01 - $276.09 $10.5 Million - $14 Million
-50,533 Reduced 14.91%
288,497 $68.2 Million
Q4 2020

Jan 28, 2021
SELL
$207.01 - $276.09 $14 Million - $18.6 Million
-67,392 Reduced 18.94%
288,497 $68.2 Million
Q3 2020

Oct 29, 2020
BUY
$255.65 - $303.1 $12.2 Million - $14.4 Million
47,537 Added 15.42%
355,889 $96.8 Million
Q2 2020

Jul 20, 2020
BUY
$225.48 - $295.8 $51.5 Million - $67.6 Million
228,379 Added 285.57%
308,352 $89.5 Million
Q1 2020

Apr 30, 2020
BUY
$199.77 - $247.81 $9.45 Million - $11.7 Million
47,325 Added 144.96%
79,973 $19 Million
Q4 2019

Feb 06, 2020
BUY
$166.71 - $223.91 $656,503 - $881,757
3,938 Added 13.72%
32,648 $7.15 Million
Q3 2019

Oct 17, 2019
SELL
$166.23 - $187.09 $1.49 Million - $1.68 Million
-8,982 Reduced 23.83%
28,710 $4.86 Million
Q2 2019

Jul 19, 2019
SELL
$164.61 - $190.37 $542,225 - $627,078
-3,294 Reduced 8.04%
37,692 $6.91 Million
Q1 2019

May 02, 2019
BUY
$163.73 - $194.7 $2.58 Million - $3.07 Million
15,783 Added 62.62%
40,986 $7.54 Million
Q4 2018

Feb 08, 2019
SELL
$151.91 - $192.21 $1.82 Million - $2.31 Million
-12,012 Reduced 32.28%
25,203 $4.18 Million
Q3 2018

Oct 31, 2018
BUY
$167.73 - $192.74 $36,565 - $42,017
218 Added 0.59%
37,215 $7.17 Million
Q3 2018

Oct 25, 2018
BUY
$167.73 - $192.74 $405,571 - $466,045
2,418 Added 6.99%
36,997 $7.13 Million
Q2 2018

Aug 03, 2018
SELL
$145.72 - $169.96 $298,580 - $348,248
-2,049 Reduced 5.59%
34,579 $5.88 Million
Q1 2018

May 07, 2018
BUY
$151.6 - $177.13 $1.51 Million - $1.76 Million
9,940 Added 37.25%
36,628 $5.97 Million
Q4 2017

Jan 25, 2018
BUY
$137.28 - $155.55 $1.51 Million - $1.71 Million
11,016 Added 70.29%
26,688 $4 Million
Q3 2017

Oct 17, 2017
BUY
$148.13 - $162.24 $5,777 - $6,327
39 Added 0.25%
15,672 $2.38 Million
Q2 2017

Aug 08, 2017
BUY
N/A
14,672 Added 1526.74%
15,633 $2.01 Million
Q1 2017

Jan 19, 2021
BUY
N/A
961
961 $105,000

Others Institutions Holding VRTX

# of Institutions
1,804
Shares Held
223M
Call Options Held
1.63M
Put Options Held
1.47M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $131B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Robeco Institutional Asset Management B.V. Portfolio

Follow Robeco Institutional Asset Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email